Nocturnal problems occurring in Parkinson's disease

Neurology

Volumn 63, Issue 8 SUPPL. 3, 2004, Pages

  Grandas, Francisco ^a   Iranzo, A ^b  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIPARKINSON AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CARBAMAZEPINE; CLONAZEPAM; DONEPEZIL; LEVODOPA; MELATONIN; MIRTAZAPINE; PAROXETINE; PRAMIPEXOLE; VENLAFAXINE;

AKATHISIA; AKINESIA; BRADYKINESIA; BRAIN DEPTH STIMULATION; DISEASE EXACERBATION; DOPAMINERGIC SYSTEM; DYSKINESIA; DYSTONIA; ELECTROENCEPHALOGRAM; HUMAN; IMPOTENCE; MUSCLE RIGIDITY; MYOCLONUS; NEUROLOGIC DISEASE; PARASOMNIA; PARKINSON DISEASE; PERIODIC LIMB MOVEMENT SYNDROME; PRIORITY JOURNAL; REM SLEEP; RESTLESS LEGS SYNDROME; REVIEW; SLEEP APNEA SYNDROME; SLEEP DISORDER; SOMNOLENCE; SUBTHALAMIC NUCLEUS; TREMOR; URINE INCONTINENCE;

EID: 7044254699     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.63.8_suppl_3.s8     Document Type: Review

References (30)

1. Partinen M. Sleep disorder related to Parkinson's disease. J Neurol 1997;244(suppl 1):S3-6.
2. Factor SA, McAlarney T, Sanchez-Ramos JR, Weiner WJ. Sleep disorders and sleep effect in Parkinson's disease. Mov Disord 1990;5:280-285.
3. Tandberg E, Larsen JP, Karlsen K. A community-based study of sleep disorders in patients with Parkinson's disease. Mov Disord 1998;13: 895-899.
4. Kumar S, Bhatia M, Behari M. Sleep disorders in Parkinson's disease. Mov Disord 2002;17:775-781.
5. Lees AJ, Blackburn NA, Campbell VL. The nighttime problems of Parkinson's disease. Clin Neuropharmacol 1988;11:512-519.
6. Singer G, Weiner W, Sanchez-Ramos JR. Autonomic dysfunction in men with Parkinson's disease. Eur Neurol 1992;32:134-140.
7. Ghorayeb I, Yekhlef F, Chrysotome V, et al. Sleep disorders and their determinants in multiple system atrophy. J Neurol Neurosurg Psychiatry 2002;72:798-800.
8. Askenasy JJ, Yahr MD. Parkinsonian tremor loses its alternating aspect during non-REM sleep and is inhibited by REM sleep. J Neurol Neurosurg Psychiatry 1990;53:749-753.
9. Askenasy JJ. Sleep in Parkinson's disease. Acta Neurol Scand 1993;87: 167-170.
10. Rye DB, Bliwise DL. Movement disorders specific to sleep and the nocturnal manifestations of waking movement disorders. In: Watts RL, Koller WC, eds. Movement disorders: neurologic principles and practice. New York: McGraw-Hill, 1997:687-713.
11. Pal PK, Calne S, Samii A, Fleming JAE. A review of normal sleep and its disturbances in Parkinson's disease. Parkinsonism Relat Disord 1999;5:1-7.
12. van Hilten B, Hoff JI, Middelkoop HA, et al. Assessment by continuous activity monitoring. Sleep disruption of Parkinson's disease. Arch Neurol 1994;51:922-928.
13. Obeso JA, Grandas F, Vaamonde J, et al. Motor complications associated with chronic levodopa therapy in Parkinson's disease. Neurology 1989;39(suppl 2):11-19.
14. Vardi J, Glaubman H, Rabey JM, Streifler M. Myoclonic attacks induced by L-dopa and bromocryptin in Parkinson patients: a sleep EEG study. J Neurol 1978;218:35-42.
15. Brugerolle B, Simon N. Biologic rhythms and Parkinson's disease: a chronopharmacologic approach to considering fluctuations in function. Clin Neuropharmacol 2002;25:194-201.
16. Stocchi F, Barbato L, Nordera G, et al. Sleep disorders in Parkinson's disease. J Neurol 1998;245(suppl 1):S15-18.
17. Grandas F, Martínez-Martín P, Linazasoro G, on behalf of the STAR Multicenter Study Group. Quality of life in patients with Parkinson's disease who transfer from standard levodopa to Sinemet CR: the STAR study. J Neurol 1998;245(suppl 1):S31-33.
18. Iranzo A, Valldeoriola F, Santamaria J, et al. Sleep symptoms and polysomnographic architecture in advanced Parkinson's disease after chronic bilateral subthalamic stimulation. J Neurol Neurosurg Psychiatry 2002;72:661-664.
19. Schenck CH, Mahowald MW. REM sleep behavior disorder: clinical, developmental, and neuroscience perspectives 16 years after its formal identification in SLEEP. Sleep 2002;25:120-138.
20. Gagnon JF, Bedard MA, Fantini MD, et al. REM sleep behavior disorder and REM sleep without atonia in Parkinson's disease. Neurology 2002;59:585-589.
21. Comella CL, Nardine TM, Diederich NJ, Stebbins GT. Sleep-related violence, injury, and REM sleep behavior disorder in Parkinson's disease. Neurology 1998;51:526-529.
22. Plazzi G, Corsini R, Provini F, et al. REM sleep behavior disorders in multiple system atrophy. Neurology 1997;48:1094-1097.
23. Iranzo A, Santamaría J, Tolosa E, on behalf of the Barcelona Multiple System Atrophy Group. Continuous positive air pressure eliminates nocturnal stridor in multiple system atrophy. Lancet 2000;356:1329-1330.
24. Boeve BF, Silber MH, Parisi JE, et al. Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism. Neurology 2003;61:40-45.
25. Iranzo A, Muñoz E, Santamaria J, et al. REM sleep behavior disorder and vocal cord paralysis in Machado-Joseph disease. Mov Disord 2003; 18:1179-1183.
26. Nomura T, Inoue Y, Mitani H, et al. Visual hallucinations as REM sleep behavior disorders in patients with Parkinson's disease. Mov Disord 2003;18:812-817.
27. Gagnon JF, Fantini ML, Bedard MA, et al. Association between waking EEG slowing and REM sleep behavior disorder in PD without dementia. Neurology 2004;62:401-406.
28. Rye DB. Modulation of normal and pathologic motoneuron activity during sleep. In: Chokroverty S, Hening WA, Walters AS, eds. Sleep and movement disorders. Philadelphia: Butterworth Heinemann, 2003:94-119.
29. Braak H, Del Tredici K, Rub U, et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003;24:197-211.
30. Albin RL, Koeppe RA, Chervib RD, et al. Decreased striatal dopaminergic innervation in REM sleep behavior disorder. Neurology 2000;55: 1410-1412.